Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age

NCT01031303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Poliomyelitis

Interventions

BIOLOGICAL: DTacP-IPV combined vaccine (TETRAXIM™)

Sponsor

Sanofi